Comparison of activation effort for hematology/oncology studies versus non-hematology/oncology studies using the investigational drug services complexity scoring tool

While the CST can estimate effort based on study complexity, it does not differentiate complexity by therapeutic area. Using real-world data based on IDS practice experience, this study confirmed that hematology/oncology studies require greater effort for certain study activation activities than non-hematology/oncology studies. There is an opportunity to continue refining the CST as a valuable tool for assessing study complexity.